Forte Biosciences (FBRX) Interest Coverage Ratio Growth (1y) (2017 - 2020)
Forte Biosciences (FBRX) Interest Coverage Ratio Growth (1y) (2017 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Forte Biosciences |
70.77 Mn |
12.55 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2020 |
88.02% |
| Dec 31, 2019 |
81.50% |
| Sep 30, 2019 |
-118.03% |
| Jun 30, 2019 |
94.13% |
| Mar 31, 2019 |
39.21% |
| Dec 31, 2018 |
6.29% |
| Sep 30, 2018 |
108.49% |
| Jun 30, 2018 |
19.77% |
| Mar 31, 2018 |
-165.10% |
| Dec 31, 2017 |
-82.72% |
| Sep 30, 2017 |
-35.64% |
| Jun 30, 2017 |
-15.84% |
| Mar 31, 2017 |
7.69% |
